Dossier · NP · Dormant
NP · Neptune Insurance Holdings Inc. · Stock research
Last analysed ·
Against its published line
The red mark is the published kill line. The dot is where the name closed on 14 August 2026. Distance is drawn on a square-root scale, so the first two points of cushion take half the track and a name sitting on its line is legible; past 8% a name reads simply as well clear. A trigger written on weekly closes is graded on weekly closes, so a name trading through such a line mid-week reads as pending, not hit.
Resolved Graded and closed 2026-08-24 at low conviction — the published kill line did not fire.
Current thesis
The 2026-07-21 beat-and-raise has round-tripped: the 2026-08-14 weekly close of $31.71 is under the $32 post-print shelf, BMO cut to Market Perform on 2026-07-30, and the CFO sold 100,000 shares into $30.74–$32.12 on Aug 12–13. Operations still compound (+33% Q2 revenue), but the fresh-attention leg is spent and nothing is dated before the ~late-October Q3 print.
Kill line
A weekly close below $30 loses the $30.74–$32.12 band held through mid-August and puts the 2026-05-13 follow-on price of $27.50 back in play; secondarily, a Q3 report (~2026-10-21, est.) that leaves the FY2026 $199M guide unraised, or no weekly close back above $32 before it, confirms the re-rating has stalled.
Pick status
Played out resolved published kill line did not fire How this is scored →Latest analysis and events for NP —
As of 16 August 2026, the latest FrontierPicks analysis for Neptune Insurance Holdings Inc. (NP): The 2026-07-21 beat-and-raise has round-tripped: the 2026-08-14 weekly close of $31.71 is under the $32 post-print shelf, BMO cut to Market Perform on 2026-07-30, and the CFO sold 100,000 shares into $30.74–$32.12 on Aug 12–13. Operations still compound (+33% Q2 revenue), but the fresh-attention leg is spent and nothing is dated before the ~late-October Q3 print.
Kill line: A weekly close below $30 loses the $30.74–$32.12 band held through mid-August and puts the 2026-05-13 follow-on price of $27.50 back in play; secondarily, a Q3 report (~2026-10-21, est.) that leaves the FY2026 $199M guide unraised, or no weekly close back above $32 before it, confirms the re-rating has stalled.
Next dated event on file: — catalyst in 15d.
Current Thesis
Neptune is a private-flood managing general agent underwriting algorithmically on its Triton platform, taking policy share from the federal National Flood Insurance Program. The prior read, written on 2026-07-26, argued the 2026-07-21 beat-and-raise had flipped narrative velocity back to accelerating and that the operative question was whether the post-print breakout held. It did not hold. The 2026-08-14 weekly close of $31.71 sits under the $32 shelf that defined the post-print hold, which round-trips the reaction to a clean quarter in roughly three weeks. Operations did not deteriorate — the company called Q2 record results with 33% revenue growth and 36% adjusted EBITDA growth — but the marginal buyer did not show up for them. On 2026-07-30 BMO Capital cut the name to Market Perform from Outperform, and the CFO sold 100,000 Class A shares on 2026-08-12 and 2026-08-13 into a $30.74–$32.12 band. The narrative is maturing. What dates it is the pairing of a fundamentally successful 2026-07-21 print with a 2026-07-30 valuation downgrade and a full price round-trip by 2026-08-14 — the story still works, the flow behind it has moderated, and there is no dated company event before the Q3 report in late October.
Bullish and bearish views on Neptune Insurance Holdings Inc.
The model's bull view on Neptune Insurance Holdings Inc. (NP), in brief: Q2 2026 (2026-07-21) beat both lines: adjusted EPS $0.15 vs $0.14 consensus, revenue $55.87M vs $52.25M consensus, with the company describing revenue +33% YoY and adjusted EBITDA +36% YoY. The bear view: The 2026-07-21 beat-and-raise has been given back. Both cases follow in full.
Bull Case
- Q2 2026 (2026-07-21) beat both lines: adjusted EPS $0.15 vs $0.14 consensus, revenue $55.87M vs $52.25M consensus, with the company describing revenue +33% YoY and adjusted EBITDA +36% YoY.
- FY2026 revenue guidance was raised on 2026-07-21 to $199M from $195M, above the $196.97M consensus — against FY2025 revenue of $159.6M that keeps growth in the mid-20s rather than slipping under 20%.
- Profitability is real by the adjusted measures the group rarely reaches: Q1 2026 (2026-04-22) adjusted EBITDA +26% to $21.6M at a 57% margin, adjusted net income +21% to $13.4M.
- Underlying volume compounding: Q1 2026 written premium +26% to $86.7M, premium in force $388.7M, policies in force 295,029 — share taken from a government monopoly line rather than from a cyclical pricing tailwind.
- The bull side of the sell-side has not capitulated after the print: Piper Sandler Overweight $39 (2026-07-15), Evercore ISI Outperform $36 (2026-07-22), Wells Fargo Overweight $37 (2026-07-23, from $35).
- NOAA's 2026-08-06 seasonal update cut the outlook to 7–13 named storms and 2–6 hurricanes with 75% odds of a below-normal season; a quiet peak removes the catastrophe tail that hangs over every coastal underwriter from August to October.
Bear Case
- The 2026-07-21 beat-and-raise has been given back. A weekly close of $31.71 on 2026-08-14 is beneath the $32 level that marked the post-print hold — a beat that does not hold its gap says the incremental bid is thin.
- BMO Capital downgraded to Market Perform from Outperform on 2026-07-30, nine days after the beat, and the cautious cluster now sits at or below the last close: JP Morgan Neutral $31 (from $30), Morgan Stanley $31 (2026-07-23, from $29), KBW Market Perform $33 (2026-07-24, from $34).
- Valuation carries the whole argument: roughly 51.8x forward earnings on a ~$4.35B market cap (stockanalysis.com, 2026-08-16), against GAAP results that carried a net loss of -$24.37M on a TTM view through Q1 2026.
- Insider supply into the tape: a Form 4 shows CFO and director James Steiner selling 42,988 shares at a $31.0755 weighted average on 2026-08-12 and 57,012 at $31.7121 on 2026-08-13, leaving 3,749,050 Class A shares held. Sponsor entities FTV and BSIV Hold 101 LP remain registered sellers of size.
- The 2026-05-13 follow-on placed 9.84M shares at $27.50 — a monetization near the highs that put float into the market three months before the current stall.
- Growth is stepping down in absolute terms: FY2025 revenue grew +34%; the FY2026 guide of $199M implies roughly +25%. The raise improved the path versus expectations without re-accelerating it.
- A below-normal season cuts both ways for an MGA: fewer flood headlines is fewer moments when uninsured homeowners buy a policy, and Q3 policy-in-force growth is the line where that shows up.
Setup & Price Structure
- Reference close 2026-08-14: $31.71, which is -9.7% from the $35.11 52-week high. RSI(14) 53.4 — no oversold condition, no momentum extension. Three-month return +13.3%, so the medium-term uptrend is intact while the post-print leg is not.
- The August band is unusually well documented: the CFO's Form 4 discloses trades executed between $30.74 and $31.45 on 2026-08-12 and between $30.87 and $32.12 on 2026-08-13. That $30.7–$32.1 range is the shelf currently being defended.
- Overhead: $32 is the round-trip line from 2026-07-21; above it the $33–$35.11 zone requires estimate revisions that JP Morgan, Morgan Stanley and KBW are not currently underwriting at $31/$31/$33.
- Beneath: the 2026-05-13 follow-on cleared 9.84M shares at $27.50, the last large-block clearing price on the tape.
- Crowding observables, without a verdict on them: a dozen-plus desks cover the name inside its first year public; targets straddle spot in two clusters ($31–$33 cautious, $36–$39 bullish); a $100M buyback authorized 2026-04-21 sits as a potential company bid with no intra-quarter disclosure of pace; and insider plus sponsor selling has been the visible flow of the last quarter.
Catalyst Calendar (next 30 days)
- 2026-09-10 — climatological peak of the Atlantic hurricane season. Not a company event; the daily NHC tropical outlook is the live feed. Season to date: two named storms (Arthur, Bertha), no hurricanes as of NOAA's 2026-08-06 update.
- ~2026-10-21 (est.) — Q3 2026 results. Outside the 30-day window. Date estimated from the reporting cadence: Q1 on 2026-04-22, Q2 on 2026-07-21, both roughly three weeks after quarter end.
- ~early October 2026 (est.) — the press release announcing the Q3 date; the company has historically pre-announced roughly two weeks ahead.
- No confirmed dated company catalyst falls inside the next 30 days. Anything that moves the name before late October arrives unscheduled: a storm, an analyst action, or a filed block sale.
What Would Change Our Mind
The structure that already broke is the post-print shelf: a beat-and-raise on 2026-07-21 that was fully given back by the 2026-08-14 weekly close of $31.71 is the single most informative datapoint in this refresh, and it is what moved the label from accelerating to maturing. From here the read breaks on a weekly close below $30, which loses the $30.74–$32.12 band the stock has held through mid-August and puts the 2026-05-13 follow-on price of $27.50 in play as the next reference. Secondarily, a Q3 report in late October that leaves the FY2026 $199M guide unraised, or shows written-premium growth under 20%, would confirm that the re-rating has stalled on fundamentals rather than on multiple alone — as would a second desk following BMO's 2026-07-30 downgrade on valuation. The read improves on the reverse: a weekly close back above $32, then $33, with the Q3 print raising the FY guide again, would restore the accelerating frame and make the bull cluster's $36–$39 targets the operative range rather than a leftover from July.
Correlation Notes
- Coastal property and specialty insurers: the group trades off the same seasonal cat-risk premium. NOAA's 2026-08-06 downgrade to 75% odds of a below-normal season compresses that premium for everyone, so Neptune's idiosyncratic policy-growth line is what has to carry the stock through September.
- High-multiple growth complex: at roughly 51.8x forward earnings, the name behaves like a long-duration growth asset. Multiple compression in growth software and insurtech transmits here regardless of flood fundamentals.
- The reference point is not the loss-making insurtech cohort's operating profile but its valuation regime — adjusted EBITDA at a 57% Q1 margin separates the fundamentals, not the multiple.
- Federal policy: the economics depend on the price and coverage gap versus the NFIP. Any reauthorization or rate-reform headline out of Washington changes the spread Neptune underwrites against, in either direction.
- Float and supply: with a 2026-05-13 follow-on at $27.50 and sponsor holders still registered, the name trades with a supply overhang that most seasoned insurers do not carry.
Notes
- Neptune is a private-flood MGA (parent of Neptune Flood). Earlier theme tags of managed-care or AI-datacenter on this ticker were misclassifications and should not be re-applied.
- Atlantic hurricane season runs June to November with a statistical peak near September 10; landfall risk is an unscheduled, two-sided catalyst on any trading day inside that window.
- Sponsor entities FTV and BSIV Hold 101 LP remain large registered Class A holders and have sold multi-million-share blocks; secondary supply is a standing feature of the float.
- Company guides and reports on adjusted EBITDA and adjusted EPS; GAAP results carried a net loss of -$24.37M on a TTM view through Q1 2026.
- A $100M buyback was authorized 2026-04-21; the company does not disclose repurchase pace intra-quarter, so the company bid is unobservable until the next filing.
- Reporting cadence has run roughly three weeks after quarter end (Q1 on 2026-04-22, Q2 on 2026-07-21), so the Q3 date can land earlier than aggregator estimates.
Related · shared themes
HUM
Humana Inc.
Margin-over-volume Medicare Advantage reset reclaimed its trend: the 2026-08-24 close of $386.61 is 2.0% above the prior session and back clear of the last 50-day value observed ($378.33, 2026-08-12), with RSI(14) at 64.6 from 52.5. Revision flow idle since Bernstein's 08-14 Buy/$425, and the 2027 number now has a venue — a 2026-12-10 investor update — past both the 09-08/10 conference window and the 11-06 print. The narrative is maturing.
RXO
RXO, Inc.
Freight-cycle recovery intact; sell-side has fully caught up into a $20–35 battleground — bears $20 (Goldman 07-16, Susquehanna 07-14), bulls $30–35 (BMO $35 initiation 07-14, Stifel/Truist/Citi $30). Narrative matured from mispriced to consensus; the ~2026-08-05 Q2 print (adj EBITDA guide $27–37M vs $6M Q1) is the binary the whole re-rate discounts.
CNC
Centene Corporation
Margin-repair guide raise of 2026-07-28 stays fully priced: the 2026-08-24 close of $65.65 is 2.7% under the 2026-08-14 close of $67.47 and 4.5% below the $68.72 52-week high, with no analyst target moved since Argus on 2026-08-11. maturing; the next company-controlled datapoint is Q3, now calendared 2026-10-27.
HNGE
Hinge Health, Inc.
Digital-MSK profitability re-rate broke out in May and was pushed into open price discovery by the 2026-06-09 mid-quarter raise (Q2 to $200–202M, +45%; FY26 to $818–824M). But nine sell-side target hikes in two weeks plus accelerating insider selling mark a late, distribution-prone phase, with no company catalyst until the ~2026-08-04 Q2 print.